NextPlat to Acquire Pensacola-Area Pharmacy, Expanding Florida Footprint and Adding Approximately $5.6 Million in Profitable Annual Revenue

NextPlat Corp (NASDAQ: NXPL) has announced the strategic acquisition of an independent pharmacy located in a rural community near Pensacola, Florida, for a total cash consideration of $1.5 million. The transaction is expected to close in the fourth quarter of 2026, pending due diligence and customary closing conditions. This acquisition aims to enhance NextPlat's PharmcoRx retail footprint and service offerings in an underserved market, where the pharmacy generated approximately $5.6 million in sales for the year ending December 31, 2025.

The independent pharmacy, which has been serving the local community for over 25 years, provides a range of services including prescription medication fulfillment, over-the-counter products, durable medical equipment, and healthcare advisory services. Its established presence in a market often overlooked by larger national chains positions it as a valuable asset for NextPlat, which seeks to leverage this acquisition to expand its healthcare services. The pharmacy operates profitably with positive working capital and a debt-free balance sheet, making it a strategic addition to NextPlat's portfolio.

NextPlat's PharmcoRx division currently operates four specialty pharmacies in central and southern Florida, focusing on full-service prescription fulfillment and integrated patient support. The company plans to introduce additional services at the newly acquired pharmacy, including same-day delivery and online fulfillment, which are expected to enhance patient engagement and satisfaction. Moreover, NextPlat aims to market its contracted services to healthcare providers participating in the government’s 340B Drug Pricing Program, as well as long-term care facilities and other institutional providers in the greater Pensacola area.

The acquisition aligns with NextPlat's broader strategy to diversify its healthcare operations and replicate its successful business model in underserved markets. The company anticipates organic growth of approximately 20% in 2026, driven by an increase in higher-margin contracted services. This move not only expands PharmcoRx's reach but also positions the company to capitalize on growth opportunities within a sector that is increasingly focused on accessibility and quality of care.

Overall, this transaction reflects a growing trend in the healthcare sector where companies are seeking to enhance their service offerings and expand their geographic presence through strategic acquisitions. As NextPlat integrates the independent pharmacy into its operations, it will likely contribute to the company's overall revenue growth while addressing the healthcare needs of communities that are often neglected by larger retail chains. The successful execution of this strategy could further solidify NextPlat's position within the competitive landscape of healthcare services in Florida and beyond.